Dihexa vs P21 (Adamax)
Overview
Dihexa and P21 (Adamax) are both cognitive enhancement peptides, but they differ in mechanism, dosing, and regulatory status.
This page compares Dihexa and P21 (Adamax) across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Dihexa | P21 (Adamax) | |
|---|---|---|
| Category | Cognitive Enhancement | Cognitive Enhancement |
| Regulatory status (US) | Compounding (Rx) — Apr 2026 | Research use only |
| Typical dosage | Research protocols vary | 5-20 mg |
| Frequency | research | intermittent |
| Reported benefits | Powerful cognitive enhancement, potential neuroregeneration, memory improvement | Enhanced learning, neuroplasticity, memory formation |
| Reported side effects | Research compound. Long-term effects unknown | Research compound, limited data |
Key differences
Primary use. Dihexa is categorised under Cognitive Enhancement, while P21 (Adamax) falls under Cognitive Enhancement. Because they target a similar goal, they are common alternatives to weigh against each other.
Regulatory status. Dihexa: not FDA-approved; compounding permitted with a prescription as of April 2026. P21 (Adamax): not FDA-approved; treated as a research compound.
Dosing. Dihexa is typically dosed at Research protocols vary (research). P21 (Adamax) is typically dosed at 5-20 mg (intermittent).
Can you stack them?
Some protocols combine peptides, but stacking Dihexa and P21 (Adamax) has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Dihexa and P21 (Adamax)?
- Dihexa and P21 (Adamax) are both cognitive enhancement peptides, but they differ in mechanism, dosing, and regulatory status. Dihexa is not FDA-approved; compounding permitted with a prescription (as of April 2026), whereas P21 (Adamax) is not FDA-approved; generally classified as a research compound.
- What is Dihexa used for?
- Potent cognitive enhancer.
- What is P21 (Adamax) used for?
- Neurogenic peptide.
- Can you take Dihexa and P21 (Adamax) together?
- Some users combine peptides within a single protocol, but stacking Dihexa and P21 (Adamax) has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Dihexa or P21 (Adamax) FDA-approved?
- Dihexa is not FDA-approved; compounding permitted with a prescription (as of April 2026). P21 (Adamax) is not FDA-approved; generally classified as a research compound.
Read the full articles
- Dihexa — full monograph: mechanism, research, dosing & references
- P21 (Adamax) — full monograph: mechanism, research, dosing & references